(Q39758568)

14 September 2017

Influence of ligand binding kinetics on functional inhibition of human recombinant serotonin and norepinephrine transporters (English)

1 reference

14 September 2017

0 references

0 references

1 reference

William J Martin

3

0 references

author name string

Pamela R Tsuruda

1

1 reference

14 September 2017

Joey Yung

2

1 reference

14 September 2017

Ray Chang

4

1 reference

14 September 2017

Ngoc Mai

5

1 reference

14 September 2017

Jacqueline A M Smith

6

1 reference

14 September 2017

28 December 2009

1 reference

Journal of Pharmacological and Toxicological Methods

14 September 2017

1 reference

14 September 2017

61

1 reference

14 September 2017

2

1 reference

14 September 2017

192-204

1 reference

A new look at the statistical model identification

14 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.12.003

Location of the antidepressant binding site in the serotonin transporter: importance of Ser-438 in recognition of citalopram and tricyclic antidepressants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.12.003

Antidepressants targeting the serotonin reuptake transporter act via a competitive mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.12.003

The binding sites for cocaine and dopamine in the dopamine transporter overlap

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.12.003

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.12.003

Binding characteristics of selective serotonin reuptake inhibitors with relation to emission tomography studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.12.003

Comparative evaluation in nonhuman primates of five PET radiotracers for imaging the serotonin transporters: [11C]McN 5652, [11C]ADAM, [11C]DASB, [11C]DAPA, and [11C]AFM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.12.003

Validation of a fluorescence-based high-throughput assay for the measurement of neurotransmitter transporter uptake activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.12.003

Differential inhibitory effects of drugs acting at the noradrenaline and 5-hydroxytryptamine transporters in rat and human neocortical synaptosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.12.003

Kinetic and thermodynamic assessment of binding of serotonin transporter inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.12.003

Desvenlafaxine succinate identifies novel antagonist binding determinants in the human norepinephrine transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.12.003

Identification and characterization of pseudoirreversible nonpeptide antagonists of the neuropeptide Y Y5 receptor and development of a novel Y5-selective radioligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.12.003

Studies of the biogenic amine transporters. XI. Identification of a 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR12909) analog that allosterically modulates the serotonin transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.12.003

The kinetics of action of acetylcholine antagonists in smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.12.003

The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.12.003

Antidepressant binding site in a bacterial homologue of neurotransmitter transporters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.12.003

SNRIs: The Pharmacology, Clinical Efficacy, and Tolerability in Comparison with Other Classes of Antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.12.003

Fluoxetine (Prozac) binding to serotonin transporter is modulated by chloride and conformational changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.12.003

Plasma membrane monoamine transporters: structure, regulation and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.12.003

Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.12.003

Sartan-AT1 receptor interactions: in vitro evidence for insurmountable antagonism and inverse agonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.12.003

LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.12.003

Antidepressant specificity of serotonin transporter suggested by three LeuT-SSRI structures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.12.003

10.1016/J.VASCN.2009.12.003

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference